The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Endocrine morbidity in midline brain defects: Differences between septo-optic dysplasia and related disorders
Abstract
BACKGROUND: Septo-optic dysplasia (SOD) is a heterogeneous congenital condition. The aim of this study was to investigate the clinical phenotypes of a large cohort of children with SOD, Multiple Pituitary Hormone Deficiency (MPHD) and Optic Nerve Hypoplasia (ONH), with a focus on endocrine testing. METHODS: Retrospective single-centre longitudinal study of children with SOD (n:171), MPHD (n:53) and ONH (n:35). SOD+ and SOD- indicate patients with or without hypopituitarism, respectively. FINDINGS: All deficits were more frequent and occurred earlier in MPHD than SOD+ [Hazard Ratios (HR): 0·63(0·45,0·89) for GH, 0·48(0·34,0·69) for TSH, 0·55(0·38,0·80) for ACTH, 0·28(0·11,0·68) for gonadotropins], except Diabetes Insipidus (DI) [HR: 2·27(0·88,5·9)]. Severe hypothalamo-pituitary (H-P) abnormalities were more frequent in MPHD [80·0% vs 41·6%, p<0·0001 for Ectopic Posterior Pituitary (EPP)]. Stalk and PP abnormalities were associated with more severe endocrine phenotypes and placed a subgroup of SOD+ at risk of developing deficits earlier. SOD and ONH shared heterogeneous phenotypes ranging from pubertal delay to precocity and from leanness to extreme obesity, whilst MPHD had GnD and obesity only. Mortality was recorded in 4·2% (6/144) SOD and 3·2% (1/31) ONH, and only in patients with multisystem phenotypes. INTERPRETATION: More than a single disease, SOD represents a spectrum of malformative conditions involving different brain structures and characterised by a dynamic and sequential nature of endocrine. In contrast, MPHD displays a more homogeneous phenotype of (mainly) anterior pituitary early-onset failure. Stalk and PP abnormalities place a subgroup of SOD+ at a higher risk of early-onset deficits. Additionally, there are striking differences between the SOD and MPHD cohorts in terms of pubertal progression. The shared phenotypes between ONH and SOD could be partly explained by common hypothalamic dysfunction. The differences between the cohorts are important as they may aid in planning management and preventing morbidity by dictating earlier interventions. FUNDING: M.C., M.G., and N.I. were supported by the European Society of Paediatric Endocrinology (ESPE) through ESPE Clinical Fellowships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypothalamic obesity develops in 31% of patients with SOD and can even occur in 12% of patients with isolated optic nerve hypoplasia (90).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Self-citationPersani, L., Brabant, G., Dattani, M., Bonomi, M., Feldt-Rasmussen, U., Fliers, E., Gruters, A., Maiter, D., Schoenmakers, N., & van Trotsenburg, A. S. P. (2018) · European Thyroid Journal · doi:10.1159/000491388 · Cited by 222
Self-citationExcess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies
Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3787 · Cited by 138
Research works printed but not linked: 34
- Patel, 2006, Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England, J Pediatr, 148, 85, 10.1016/j.jpeds.2005.07.031 · DOI · Paper page
- Garne, 2018, Epidemiology of septo-optic dysplasia with focus on prevalence and maternal age - A EUROCAT study, Eur J Med Genet, 61, 483, 10.1016/j.ejmg.2018.05.010 · doi:10.1016/j.ejmg.2018.05.010
- Garcia-Filion, 2013, Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations, Curr Treat Options Neurol, 15, 78, 10.1007/s11940-012-0209-2 · DOI
- Kelberman, 2007, Genetics of septo-optic dysplasia, Pituitary, 10, 393, 10.1007/s11102-007-0055-5 · DOI
- Fang, 2016, Genetics of combined pituitary hormone deficiency: roadmap into the genome era, Endocr Rev, 37, 636, 10.1210/er.2016-1101 · DOI · Paper page
- Atapattu, 2012, Septo-optic dysplasia: antenatal risk factors and clinical features in a regional study, Horm Res Paediatr, 78, 81, 10.1159/000341148 · doi:10.1159/000341148
- Birkebaek, 2003, Endocrine status in patients with optic nerve hypoplasia: relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging, J Clin Endocrinol Metab, 88, 5281, 10.1210/jc.2003-030527 · DOI
- Deal, 2013, Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study, Horm Res Paediatr, 79, 283, 10.1159/000350829 · DOI
- Freude, 1992, Septo-optic dysplasia and growth hormone deficiency: accelerated pubertal maturation during GH therapy, Acta Paediatr., 81, 641, 10.1111/j.1651-2227.1992.tb12321.x · doi:10.1111/j.1651-2227.1992.tb12321.x
- Huseman, 1978, Sexual precocity in association with septo-optic dysplasia and hypothalamic hypopituitarism, J Pediatr, 92, 748, 10.1016/S0022-3476(78)80142-5 · doi:10.1016/s0022-3476(78)80142-5
- Mehta, 2009, Congenital hypopituitarism: clinical, molecular and neuroradiological correlates, Clin Endocrinol, 71, 376, 10.1111/j.1365-2265.2009.03572.x · DOI
- Riedl, 2008, Refining clinical phenotypes in septo-optic dysplasia based on MRI findings, Eur J Pediatr, 167, 1269, 10.1007/s00431-007-0666-x · DOI
- Secco, 2011, Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia, Eur J Endocrinol, 165, 411, 10.1530/EJE-11-0437 · DOI
- Vedin, 2011, Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia, Int J Pediatr Endocrinol, 2011, 17, 10.1186/1687-9856-2011-17 · doi:10.1186/1687-9856-2011-17
- Webb, 2010, Septo-optic dysplasia, Eur J Hum Genet., 18, 393, 10.1038/ejhg.2009.125 · DOI · Paper page
- Spiliotis, 1984, Growth hormone neurosecretory dysfunction. A treatable cause of short stature, JAMA, 251, 2223, 10.1001/jama.1984.03340410031028 · DOI · Paper page
- DeVile, 1996, Growth and endocrine sequelae of craniopharyngioma, Arch Dis Child, 75, 108, 10.1136/adc.75.2.108 · DOI · Paper page
- Freeman, 1995, Cross sectional stature and weight reference curves for the UK, 1990, Arch Dis Child, 73, 17, 10.1136/adc.73.1.17 · DOI · Paper page
- Bedogni, 2012, Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients, Growth Horm IGF Res, 22, 134, 10.1016/j.ghir.2012.04.005 · doi:10.1016/j.ghir.2012.04.005
- Bar, 2015, Pituitary stalk interruption syndrome from infancy to adulthood: clinical, hormonal, and radiological assessment according to the initial presentation, PloS One, 10, 10.1371/journal.pone.0142354 · DOI
- Traggiai, 2002, Endocrinopathies associated with midline cerebral and cranial malformations, J Pediatr, 140, 252, 10.1067/mpd.2002.121822 · DOI
- Blum, 2013, Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency, Eur J Endocrinol, 170, 13, 10.1530/EJE-13-0643 · DOI
- Morishima, 1986, Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum, Brain Dev, 8, 233, 10.1016/S0387-7604(86)80075-4 · doi:10.1016/s0387-7604(86)80075-4
- Nanduri, 1999, Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?, Eur J Endocrinol., 140, 48, 10.1530/eje.0.1400048 · DOI
- Hanna, 1989, Puberty in the syndrome of septo-optic dysplasia, Am J Dis Child, 143, 186
- Fitz, 1994, Holoprosencephaly and septo-optic dysplasia, Neuroimaging Clin N Am, 4, 263, 10.1016/S1052-5149(25)00765-8 · doi:10.1016/s1052-5149(25)00765-8
- Bauer, 1954, Endocrine and other clinical manifestations of hypothalamic disease; a survey of 60 cases, with autopsies, J Clin Endocrinol Metab, 14, 13, 10.1210/jcem-14-1-13 · DOI
- Gan, 2015, Neuroendocrine morbidity after pediatric optic gliomas: a longitudinal analysis of 166 children over 30 years, J Clin Endocrinol Metab, 100, 3787, 10.1210/jc.2015-2028 · DOI
- Alyahyawi, 2018, Pituitary Dysfunction in pediatric patients with optic nerve hypoplasia: a retrospective cohort study (1975-2014), Horm Res Paediatr, 89, 22, 10.1159/000484046 · doi:10.1159/000484046
- Stanhope, 1986, High resolution CT scanning of the pituitary gland in growth disorders, Acta Paediatr Scand, 75, 779, 10.1111/j.1651-2227.1986.tb10290.x · DOI
- Maghnie, 2004, Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate, J Endocrinol Invest, 27, 496, 10.1007/BF03345298 · doi:10.1007/bf03345298
- Garcia-Filion, 2008, Neuroradiographic, endocrinologic, and ophthalmic correlates of adverse developmental outcomes in children with optic nerve hypoplasia: a prospective study, Pediatrics, 121, e653, 10.1542/peds.2007-1825 · doi:10.1542/peds.2007-1825
- Dahl, 2019, High prevalence of pituitary hormone deficiency in both unilateral and bilateral optic nerve hypoplasia, Acta Paediatr, 108, 1677, 10.1111/apa.14751 · doi:10.1111/apa.14751
- Tomlinson, 2001, Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group, Lancet, 357, 425, 10.1016/S0140-6736(00)04006-X · DOI · Paper page
Cited by
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
Metadata
- Authors
- Cerbone, M., Güemes, M., Wade, A., Improda, N., & Dattani, M.
- Venue
- EClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 19
- Pages
- 100224
- ISSN
- 2589-5370
- Cited by
- 42
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- NIHR Bristol Biomedical Research Centre
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine morbidity in midline brain defects: Differences between septo-optic dysplasia and related disorders. https://app.cochat.ai/papers/10.1016/j.eclinm.2019.11.017
- The paper
- Cerbone, M., Güemes, M., Wade, A., Improda, N., & Dattani, M. (2020). Endocrine morbidity in midline brain defects: Differences between septo-optic dysplasia and related disorders. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2019.11.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.